
浏览全部资源
扫码关注微信
纸质出版日期:2014
移动端阅览
刘萨仁, 佟玉清, 金桃, 等. 蒙药辅助治疗老年慢性心衰患者的临床疗效[J]. 中国实验方剂学杂志, 2014,20(7):208-211.
LIU Sa-ren, TONG Yu-qing, JIN Tao, et al. Clinical Effects of Adjuvant Therapy on Elderly Chronic Heart Failure Patients with Traditional Mongolian Medicine[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(7): 208-211.
刘萨仁, 佟玉清, 金桃, 等. 蒙药辅助治疗老年慢性心衰患者的临床疗效[J]. 中国实验方剂学杂志, 2014,20(7):208-211. DOI: 10.13422/j.cnki.syfix.2014070208.
LIU Sa-ren, TONG Yu-qing, JIN Tao, et al. Clinical Effects of Adjuvant Therapy on Elderly Chronic Heart Failure Patients with Traditional Mongolian Medicine[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(7): 208-211. DOI: 10.13422/j.cnki.syfix.2014070208.
目的:探讨蒙药治疗老年慢性心力衰竭(CHF)患者的临床疗效及对患者血液流变学、血浆D-二聚体的影响。方法:将108例老年CHF患者随机按入院前后分成对照组和观察组各54例。对照组采用西药强心、利尿、扩血管等常规治疗;观察组在对照组治疗的基础上加用蒙药治疗,达力-16味散每次5 g早饭后口服,蒺藜-3味汤每次5 g午饭后口服,绍沙-7味丸每次3 g晚睡前口服。两组疗程均为12周。进行治疗前后纽约心脏病协会(NYHA)心功能分级和Lee氏心衰计分;采用超声心动图测定治疗前后心室射血分数(LVEF)、左室舒张末期内径(LVDD)和心输出量(CO);进行治疗前后血液流变学、血浆D-二聚体和血浆N端脑钠肽前体(NT-proBNP)检测。结果:治疗后观察组总有效率为87.04%优于对照组的70.37%(P<0.05);治疗后观察组Lee氏心衰积分低于对照组(P<0.01);治疗后观察组LVDD低于对照组(P<0.05);观察组LVEF和CO高于对照组(P<0.01);治疗后观察组NT-proBNP,D-二聚体水平低于对照组(P<0.01);治疗后观察组全血黏度、红细胞变形指数、纤维蛋白原的改善优于对照组(P<0.05)。结论:在西医常规治疗的基础上给予老年CHF患者达力-16味散、蒺藜-3味汤和绍沙-7味丸3种蒙药治疗,能改善老年CHF患者心功能,减轻临床症状,提高临床疗效;还能改善患者血液流变学及血液高凝状态,值得临床使用。
Objective: The purpose is to discuss the clinical effects of traditional Mongolian medicine to treat chronic cardiac failure(CHF) and influence of hemorheology
plasma D-dimer on patients. Method: One hundred and eight cases of patients with were randomly divided into control group (54 cases) and observation group (54 cases).In control group
patients were treated with western medicine conventional therapy by cardiac
diuresis
vascular dilation and so on. In observation group
besides based on control group
patients added traditional Mongolian medicine
Dali-16 wei san 5 g
taken orally after breakfast;Jili-3 wei decoction 5 g
taken orally after lunch;Shaosha-7wei pill 3 g
taken orally before sleep.Both groups were treated for 12 weeks.Record New york heart association(NYHA) cardiac functional grading and Lee's heart failure scores before and after treatment.Measure the left ventricular ejection fraction (LVEF)
left ventricular end diastolic diameter(LVDD) and cardiac output(CO) by ultrasonic cardiogram at pretherapy and post-treatment.Detect hemorheology
plasma D-dimer and N-terminal plasma brain natriuretic peptide precursor (NT-proBNP)before and after treatment. Result: After treatment
the total effective rate of the observation group was 87.4% superior to 70.37% of the control group(P<0.05). the Lee's heart failure scores of the observation group were lower than the control group(P<0.01)
Left ventricular end diastolic dimension(LDVV) of the observation group was lower than the control group(P<0.05)
LVEF and CO of the observation group were higher than the the control group(P<0.01). The level of NT-proBNP and D-dimer of the observation group were lower than the control group(P<0.01). The improvement of blood viscosity
erythrocyte deformation index(RCD) and fibrinogen of the observation group were superior to the control group(P<0.05). Conclusion: Based on the routine western medicine therapy
for the elderly patients
it can improve the cardiac function
relief clinical symptom and improve clinical effects when Dali-16 wei san
Jili-3 wei decoction and Shaosha-7 wei pill of the three traditional Mongolian medicine were used in CHF.Besides
it can also improve the hemorheology and hypercoagulable state
worthy of clinical using.
0
浏览量
5
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621